Flt3L Therapy following Localized Tumor Irradiation Generates Long-Term Protective Immune Response in Metastatic Lung Cancer: Its Implication in Designing a Vaccination Strategy

Publisher： Karger

E-ISSN： 1423-0232|70|4|245-254

ISSN： 0030-2414

Source： Oncology, Vol.70, Iss.4, 2006-10, pp. : 245-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory

By Neal Zane   Sondel Paul   Bates Mary   Gillies Stephen   Herweijer Hans  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1765-1774

Springer Publishing Company

Access to resources Recommend Favorite

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

By Rydén Lisa  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Long-Term Survival after Second-Line Therapy with Docetaxel and Carboplatin and Monthly Pamidronic Acid in a Woman with Metastatic Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 29, Iss. 5, 2006-05 ,pp. : 206-208

Karger

Access to resources Recommend Favorite

TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy

By  

Current Molecular Medicine, Vol. 10, Iss. 4, 2010-06 ,pp. : 374-380

Bentham Science Publishers

Access to resources Recommend Favorite